Quest Diagnostics Incorporated (DGX) financial statements (2020 and earlier)
Company profile
| Business Address |
500 PLAZA DRIVE SECAUCUS, NJ 07094 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,192 | 135 | 195 | 410 | 182 | 192 | 187 | ||
| Cash and cash equivalents | 1,192 | 135 | 137 | 359 | 133 | 192 | 187 | ||
| Short-term investments | 58 | 51 | 49 | ||||||
| Receivables | 1,063 | 1,012 | 924 | 926 | 901 | 932 | 852 | ||
| Inventory, net of allowances, customer advances and progress billings | 123 | 99 | 95 | 82 | 84 | 110 | 91 | ||
| Inventory | 123 | 99 | 95 | 82 | 84 | 110 | 91 | ||
| Prepaid expense | 3 | 14 | 37 | 14 | 41 | 44 | |||
| Disposal group, including discontinued operation | 9 | 176 | |||||||
| Other undisclosed current assets | 109 | 130 | 55 | 90 | 117 | 325 | 253 | ||
| Total current assets: | 2,490 | 1,390 | 1,306 | 1,531 | 1,501 | 1,603 | 1,383 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 518 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 1,453 | 1,288 | 1,145 | 1,029 | 925 | 933 | 805 | ||
| Long-term investments and receivables | 482 | 436 | 462 | 443 | 473 | 63 | 58 | ||
| Long-term investments | 482 | 436 | 462 | 443 | 473 | 63 | 58 | ||
| Intangible assets, net (including goodwill) | 7,740 | 7,770 | 7,454 | 6,949 | 6,889 | 7,103 | 6,545 | ||
| Goodwill | 6,619 | 6,563 | 6,335 | 6,000 | 5,905 | 6,032 | 5,649 | ||
| Intangible assets, net (excluding goodwill) | 1,121 | 1,207 | 1,119 | 949 | 984 | 1,071 | 896 | ||
| Other noncurrent assets | 160 | 119 | 136 | 148 | 174 | 238 | 215 | ||
| Other undisclosed noncurrent assets | (63) | (58) | |||||||
| Total noncurrent assets: | 10,353 | 9,613 | 9,197 | 8,569 | 8,461 | 8,274 | 7,565 | ||
| TOTAL ASSETS: | 12,843 | 11,003 | 10,503 | 10,100 | 9,962 | 9,877 | 8,948 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,041 | 1,021 | 1,021 | 975 | 1,014 | 1,191 | 920 | ||
| Accounts payable | 263 | 222 | 224 | 261 | 279 | ||||
| Accrued liabilities | 223 | 274 | 246 | 254 | 257 | ||||
| Employee-related liabilities | 287 | 249 | 325 | 316 | 305 | 364 | 283 | ||
| Taxes payable | 27 | 17 | 9 | 3 | 4 | 63 | 7 | ||
| Interest and dividends payable | 116 | 118 | 107 | 108 | 107 | ||||
| Other undisclosed accounts payable and accrued liabilities | 125 | 141 | 110 | 33 | 62 | 764 | 630 | ||
| Debt | 949 | 464 | 36 | 6 | 159 | 518 | 212 | ||
| Total current liabilities: | 1,990 | 1,485 | 1,057 | 981 | 1,173 | 1,709 | 1,132 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 3,966 | 3,429 | 3,748 | 3,728 | 3,492 | 3,244 | 3,120 | ||
| Long-term debt, excluding current maturities | 3,966 | 3,429 | 3,748 | 3,728 | 3,492 | 3,244 | |||
| Finance lease, liability | 30 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, liability | 413 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed long-term debt and lease obligation | (443) | 3,120 | |||||||
| Liabilities, other than long-term debt | 711 | 745 | 663 | 654 | 514 | 798 | 915 | ||
| Deferred tax liabilities, net | ✕ | 204 | 192 | ||||||
| Other liabilities | 711 | 745 | 663 | 654 | 514 | 594 | 723 | ||
| Other undisclosed noncurrent liabilities | 413 | (204) | (192) | ||||||
| Total noncurrent liabilities: | 5,090 | 4,174 | 4,411 | 4,382 | 4,006 | 3,838 | 3,843 | ||
| Total liabilities: | 7,080 | 5,659 | 5,468 | 5,363 | 5,179 | 5,547 | 4,975 | ||
| Temporary equity, carrying amount | 76 | 77 | 80 | 77 | 70 | ||||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 5,641 | 5,216 | 4,921 | 4,628 | 4,684 | 4,301 | 3,948 | ||
| Common stock | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||
| Treasury stock, value | (5,218) | (4,996) | (4,783) | (4,460) | (3,960) | (3,815) | (3,783) | ||
| Additional paid in capital | 2,722 | 2,667 | 2,612 | 2,545 | 2,481 | 2,418 | 2,379 | ||
| Accumulated other comprehensive loss | (39) | (59) | (48) | (72) | (38) | (27) | (8) | ||
| Retained earnings | 8,174 | 7,602 | 7,138 | 6,613 | 6,199 | 5,723 | 5,358 | ||
| Stockholders' equity attributable to noncontrolling interest | 46 | 51 | 34 | 32 | 29 | 29 | 25 | ||
| Total stockholders' equity: | 5,687 | 5,267 | 4,955 | 4,660 | 4,713 | 4,330 | 3,973 | ||
| TOTAL LIABILITIES AND EQUITY: | 12,843 | 11,003 | 10,503 | 10,100 | 9,962 | 9,877 | 8,948 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7,726 | 7,531 | 7,709 | 7,515 | 7,493 | 7,435 | 7,146 | |
| Revenue, net | ✕ | 7,531 | 7,709 | 7,515 | 7,493 | 7,435 | 7,146 | |
| Cost of revenue | (5,037) | (4,926) | (4,719) | (4,616) | (4,657) | (4,637) | (4,326) | |
| Gross profit: | 2,689 | 2,605 | 2,990 | 2,899 | 2,836 | 2,798 | 2,820 | |
| Operating expenses | (1,553) | (1,518) | (1,824) | (1,635) | (1,426) | (2,255) | (2,207) | |
| Other operating income (expense), net | 95 | 14 | (1) | 13 | (11) | |||
| Other undisclosed operating income | 440 | 862 | ||||||
| Operating income: | 1,231 | 1,101 | 1,165 | 1,277 | 1,399 | 983 | 1,475 | |
| Nonoperating expense | (155) | (175) | (135) | (191) | (296) | (134) | (127) | |
| Investment income, nonoperating | 3 | 31 | ||||||
| Other nonoperating income (expense) | 20 | (8) | 16 | (48) | (143) | 4 | 8 | |
| Interest and debt expense | (180) | (169) | (153) | (144) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 180 | 169 | 153 | 144 | ||||
| Income from continuing operations before equity method investments, income taxes: | 1,076 | 926 | 1,030 | 1,086 | 1,103 | 849 | 1,348 | |
| Income from equity method investments | 57 | 44 | 35 | 39 | 23 | 26 | 24 | |
| Income from continuing operations before income taxes: | 1,133 | 970 | 1,065 | 1,125 | 1,126 | 875 | 1,372 | |
| Income tax expense | (247) | (182) | (241) | (429) | (373) | (262) | (500) | |
| Other undisclosed loss from continuing operations | (26) | (24) | ||||||
| Income from continuing operations: | 886 | 788 | 824 | 696 | 753 | 587 | 848 | |
| Income from discontinued operations | 20 | 5 | 35 | |||||
| Net income: | 906 | 788 | 824 | 696 | 753 | 592 | 883 | |
| Net loss attributable to noncontrolling interest | (48) | (52) | (52) | (51) | (44) | (36) | (34) | |
| Net income attributable to parent: | 858 | 736 | 772 | 645 | 709 | 556 | 849 | |
| Other undisclosed net loss available to common stockholders, basic | (3) | (3) | (3) | |||||
| Net income available to common stockholders, diluted: | 858 | 733 | 769 | 642 | 709 | 556 | 849 | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 906 | 788 | 824 | 696 | 753 | 592 | 883 | |
| Other comprehensive income (loss) | 20 | (9) | 24 | (34) | (11) | (19) | (22) | |
| Comprehensive income: | 926 | 779 | 848 | 662 | 742 | 573 | 861 | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (48) | (52) | (52) | (51) | (44) | 36 | 34 | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (72) | (68) | ||||||
| Comprehensive income, net of tax, attributable to parent: | 878 | 727 | 796 | 611 | 698 | 537 | 827 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.